Literature DB >> 19961487

Imaging mass spectrometry of gastric carcinoma in formalin-fixed paraffin-embedded tissue microarray.

Yoshifumi Morita1, Koji Ikegami, Naoko Goto-Inoue, Takahiro Hayasaka, Nobuhiro Zaima, Hiroki Tanaka, Takashi Uehara, Tomohiko Setoguchi, Takanori Sakaguchi, Hisashi Igarashi, Haruhiko Sugimura, Mitsutoshi Setou, Hiroyuki Konno.   

Abstract

The popularity of imaging mass spectrometry (IMS) of tissue samples, which enables the direct scanning of tissue sections within a short time-period, has been considerably increasing in cancer proteomics. Most pathological specimens stored in medical institutes are formalin-fixed; thus, they had been regarded to be unsuitable for proteomic analyses, including IMS, until recently. Here, we report an easy-to-use screening method that enables the analysis of multiple samples in one experiment without extractions and purifications of proteins. We scanned, with an IMS technique, a tissue microarray (TMA) of formalin-fixed paraffin-embedded (FFPE) specimens. We detected a large amount of signals from trypsin-treated FFPE-TMA samples of gastric carcinoma tissues of different histological types. Of the signals detected, 54 were classified as signals specific to cancer with statistically significant differences between adenocarcinomas and normal tissues. We detected a total of 14 of the 54 signals as histological type-specific with the support of statistical analyses. Tandem MS revealed that a signal specific to poorly differentiated cancer tissue corresponded to histone H4. Finally, we verified the IMS-based finding by immunohistochemical analysis of more than 300 specimens spotted on TMAs; the immunoreactivity of histone H4 was remarkably strong in poorly differentiated cancer tissues. Thus, the application of IMS to FFPE-TMA can enable high-throughput analysis in cancer proteomics to aid in the understanding of molecular mechanisms underlying carcinogenesis, invasiveness, metastasis, and prognosis. Further, results obtained from the IMS of FFPE-TMA can be readily confirmed by commonly used immunohistochemical analyses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19961487     DOI: 10.1111/j.1349-7006.2009.01384.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  23 in total

1.  From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry.

Authors:  Pierre Chaurand; Dale S Cornett; Peggi M Angel; Richard M Caprioli
Journal:  Mol Cell Proteomics       Date:  2010-08-23       Impact factor: 5.911

Review 2.  Molecular imaging by mass spectrometry--looking beyond classical histology.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

Review 3.  Developments and applications of mass microscopy.

Authors:  Mitsutoshi Setou; Kamlesh Shrivas; Morakot Sroyraya; Hyunjeong Yang; Yuki Sugiura; Junji Moribe; Akira Kondo; Koji Tsutsumi; Yoshishige Kimura; Nobuya Kurabe; Takahiro Hayasaka; Naoko Goto-Inoue; Nobuhiro Zaima; Koji Ikegami; Prasert Sobhon; Yoshiyuki Konishi
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

4.  High-speed MALDI-TOF imaging mass spectrometry: rapid ion image acquisition and considerations for next generation instrumentation.

Authors:  Jeffrey M Spraggins; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-09       Impact factor: 3.109

Review 5.  Imaging of intact tissue sections: moving beyond the microscope.

Authors:  Erin H Seeley; Kristina Schwamborn; Richard M Caprioli
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 6.  MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications.

Authors:  Benjamin Balluff; Cedrik Schöne; Heinz Höfler; Axel Walch
Journal:  Histochem Cell Biol       Date:  2011-07-30       Impact factor: 4.304

Review 7.  MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice.

Authors:  Michaela Aichler; Axel Walch
Journal:  Lab Invest       Date:  2015-01-26       Impact factor: 5.662

8.  Analysis of protein tyrosine phosphatase interactions with microarrayed phosphopeptide substrates using imaging mass spectrometry.

Authors:  Christopher J McKee; Harry B Hines; Robert G Ulrich
Journal:  Anal Biochem       Date:  2013-07-29       Impact factor: 3.365

9.  Visualization of sphingolipids and phospholipids in the fundic gland mucosa of human stomach using imaging mass spectrometry.

Authors:  Nobuya Kurabe; Hisaki Igarashi; Ippei Ohnishi; Shogo Tajima; Yusuke Inoue; Yoshihiko Takahashi; Mitsutoshi Setou; Haruhiko Sugimura
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15

10.  Two-dimensional graphene as a matrix for MALDI imaging mass spectrometry.

Authors:  William L Friesen; Brian J Schultz; Joel F Destino; Theodore E G Alivio; Joseph R Steet; Sarbajit Banerjee; Troy D Wood
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-01       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.